| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1034692F |
| P356 | DOI | 10.1371/JOURNAL.PONE.0134692 |
| P932 | PMC publication ID | 4529298 |
| P698 | PubMed publication ID | 26252384 |
| P5875 | ResearchGate publication ID | 280777690 |
| P50 | author | Elisabete Carolino | Q42214543 |
| P2093 | author name string | David A Stevens | |
| Karl V Clemons | |||
| Alfred M Spormann | |||
| Niaz Banaei | |||
| Janus A J Haagensen | |||
| Jose A G Ferreira | |||
| Richard B Moss | |||
| Hasan Nazik | |||
| Kevin Cohen | |||
| John C Penner | |||
| P2860 | cites work | Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference | Q28207287 |
| Biosynthesis and function of gliotoxin in Aspergillus fumigatus | Q28253295 | ||
| Pseudomonas aeruginosa possesses two putative type I signal peptidases, LepB and PA1303, each with distinct roles in physiology and virulence | Q28492970 | ||
| Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells | Q33361111 | ||
| Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth | Q33608838 | ||
| Colorimetric assay for antifungal susceptibility testing of Aspergillus species | Q33973504 | ||
| Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis. | Q34106186 | ||
| Interkingdom metabolic transformations captured by microbial imaging mass spectrometry | Q34368544 | ||
| Modified culture method detects a high diversity of fungal species in cystic fibrosis patients | Q34708759 | ||
| Aspergillus bronchitis in cystic fibrosis | Q79902680 | ||
| Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome | Q80863032 | ||
| Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus | Q80969571 | ||
| Cystic and non-cystic fibrosis Pseudomonas aeruginosa isolates are not differentiated by the quorum-sensing signaling and biofilm production | Q82313722 | ||
| Fungal respiratory infections in cystic fibrosis: a growing problem | Q82411001 | ||
| Frequency of Pseudomonas aeruginosa colonizations/infections in lung transplant recipients | Q84784706 | ||
| In vivo biofilm composition of Aspergillus fumigatus | Q84846877 | ||
| Interactions between some aural aspergillus species and bacteria | Q93794501 | ||
| Quantifying metabolic activity of filamentous fungi using a colorimetric XTT assay | Q47796336 | ||
| Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. | Q47855663 | ||
| Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. | Q50452988 | ||
| The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. | Q51134002 | ||
| Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. | Q51449327 | ||
| Pseudomonas aeruginosa lipopolysaccharide inhibits Candida albicans hyphae formation and alters gene expression during biofilm development. | Q54281395 | ||
| The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis. | Q54296123 | ||
| Fungal infections in patients with cystic fibrosis | Q57913680 | ||
| Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates | Q60451770 | ||
| The influence of respiratory bacteria and their biochemical fractions onAspergillus fumigatus | Q67244680 | ||
| Frequency of Aspergillus fumigatus isolates and antibodies to aspergillus antigens in cystic fibrosis | Q69898483 | ||
| Serodiagnosis and monitoring of Aspergillus infections after lung transplantation | Q71208890 | ||
| Aspergillus airway colonization and invasive disease after lung transplantation | Q73875975 | ||
| Allograft colonization and infections with pseudomonas in cystic fibrosis lung transplant recipients | Q74576207 | ||
| Effects of quorum-sensing deficiency on Pseudomonas aeruginosa biofilm formation and antibiotic resistance | Q77559457 | ||
| Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review | Q34910464 | ||
| Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa | Q35109394 | ||
| In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections | Q36540547 | ||
| Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis | Q36754062 | ||
| Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs | Q37036107 | ||
| Conventional or molecular measurement of Aspergillus load | Q37226612 | ||
| The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm? | Q37226633 | ||
| Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis. | Q37297126 | ||
| A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. | Q37340616 | ||
| Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates | Q37392907 | ||
| Evolving concepts in biofilm infections | Q37449114 | ||
| Bugs, biofilms, and resistance in cystic fibrosis. | Q37459089 | ||
| Impact of a transposon insertion in phzF2 on the specialized metabolite production and interkingdom interactions of Pseudomonas aeruginosa | Q37713143 | ||
| Aspergillus fumigatus biofilms in the clinical setting | Q37831360 | ||
| Basic science for the chest physician: Pseudomonas aeruginosa and the cystic fibrosis airway | Q37989818 | ||
| Effects of Aspergillus fumigatus colonization on lung function in cystic fibrosis | Q38042346 | ||
| Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective | Q38059441 | ||
| Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review | Q38101836 | ||
| Biofilm formation by Aspergillus fumigatus | Q38130319 | ||
| Differential potentiation of the virulence of the Pseudomonas aeruginosa cystic fibrosis liverpool epidemic strain by oral commensal Streptococci | Q39070624 | ||
| Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. | Q39653993 | ||
| Correlation of IgE antibody titer to Aspergillus fumigatus with decreased lung function in cystic fibrosis | Q41200929 | ||
| Molecular epidemiology of Aspergillus collected from cystic fibrosis patients | Q41627174 | ||
| Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis. | Q41698424 | ||
| IgG antibodies to Aspergillus fumigatus in cystic fibrosis: a laboratory correlate of disease activity | Q41970657 | ||
| Inhaled corticosteroids and Aspergillus fumigatus isolation in cystic fibrosis | Q42204693 | ||
| Molecular screening of 246 Portuguese Aspergillus isolates among different clinical and environmental sources | Q42214481 | ||
| An unwelcome guest: Aspergillus colonization in lung transplantation and its association with bronchiolitis obliterans syndrome | Q42542661 | ||
| A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. | Q42604401 | ||
| Efficacy of caspofungin against central nervous system Aspergillus fumigatus infection in mice determined by TaqMan PCR and CFU methods | Q42708837 | ||
| Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation | Q42851594 | ||
| Pseudomonas aeruginosa secreted factors impair biofilm development in Candida albicans | Q43164831 | ||
| Restriction endonuclease analysis of total cellular DNA of Aspergillus fumigatus isolates of geographically and epidemiologically diverse origin | Q43678014 | ||
| Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients. | Q44355443 | ||
| Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms | Q44781740 | ||
| Aspergillus and lung transplantation. | Q45285171 | ||
| Revisiting the quorum-sensing hierarchy in Pseudomonas aeruginosa: the transcriptional regulator RhlR regulates LasR-specific factors. | Q46107315 | ||
| The level of p38α mitogen-activated protein kinase activation in airway epithelial cells determines the onset of innate immune responses to planktonic and biofilm Pseudomonas aeruginosa | Q46674061 | ||
| Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study | Q47655756 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| Aspergillus fumigatus | Q134359 | ||
| biofilm | Q467410 | ||
| P304 | page(s) | e0134692 | |
| P577 | publication date | 2015-08-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Inhibition of Aspergillus fumigatus and Its Biofilm by Pseudomonas aeruginosa Is Dependent on the Source, Phenotype and Growth Conditions of the Bacterium | |
| P478 | volume | 10 |
| Q40460352 | Are Cystic Fibrosis Aspergillus fumigatus Isolates Different? Intermicrobial Interactions with Pseudomonas. |
| Q33578465 | Aspergillosis and the role of mucins in cystic fibrosis |
| Q55362858 | Aspergillus fumigatus Inhibits Pseudomonas aeruginosa in Co-culture: Implications of a Mutually Antagonistic Relationship on Virulence and Inflammation in the CF Airway. |
| Q35941017 | Biofilm Filtrates of Pseudomonas aeruginosa Strains Isolated from Cystic Fibrosis Patients Inhibit Preformed Aspergillus fumigatus Biofilms via Apoptosis |
| Q40280045 | Dirhamnolipids secreted from Pseudomonas aeruginosa modify anjpegungal susceptibility of Aspergillus fumigatus by inhibiting β1,3 glucan synthase activity |
| Q26748172 | Ecology of aspergillosis: insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus species |
| Q38867893 | Effect of Anaerobiasis or Hypoxia on Pseudomonas aeruginosa Inhibition of Aspergillus fumigatus Biofilm |
| Q36407469 | Effect of acute predation with bacteriophage on intermicrobial aggression by Pseudomonas aeruginosa |
| Q36075919 | Effects of Iron Chelators on the Formation and Development of Aspergillus fumigatus Biofilm. |
| Q92219510 | Fungal-Bacterial Interactions in Health and Disease |
| Q28818788 | Harnessing Bacterial Signals for Suppression of Biofilm Formation in the Nosocomial Fungal Pathogen Aspergillus fumigatus |
| Q59137961 | Interaction between and in cystic fibrosis |
| Q92854454 | Interactions between Aspergillus fumigatus and Pulmonary Bacteria: Current State of the Field, New Data, and Future Perspective |
| Q59807055 | Interactions of and in an Mixed Biofilm Model: Does the Strain Matter? |
| Q89287398 | Interdependence between iron acquisition and biofilm formation in Pseudomonas aeruginosa |
| Q64062677 | Intermicrobial interaction: Aspergillus fumigatus siderophores protect against competition by Pseudomonas aeruginosa |
| Q35862783 | Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies |
| Q58075905 | Iron: an essential nutrient for Aspergillus fumigatus and a fulcrum for pathogenesis |
| Q61446623 | Klebsiella pneumoniae prevents spore germination and hyphal development of Aspergillus species |
| Q57174565 | Microbial Interactions in the Cystic Fibrosis Airway |
| Q36200942 | Natural products as mediators of disease. |
| Q37500602 | Pathogenesis of Fungal Infections in Cystic Fibrosis. |
| Q91711754 | Phenotypical Characteristics of the Black Yeast Exophiala dermatitidis Are Affected by Pseudomonas aeruginosa in an Artificial Sputum Medium Mimicking Cystic Fibrosis-Like Conditions |
| Q89729463 | Pseudomonas aeruginosa polymicrobial interactions during lung infection |
| Q49996658 | Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis. |
| Q40102513 | Small Colony Variants of Pseudomonas aeruginosa Display Heterogeneity in Inhibiting Aspergillus fumigatus Biofilm |
| Q46617267 | Studies of Pseudomonas aeruginosa Mutants Indicate Pyoverdine as the Central Factor in Inhibition of Aspergillus fumigatus Biofilm |
| Q40062783 | The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung. |
| Q49192235 | Verapamil Inhibits Aspergillus Biofilm, but Antagonizes Voriconazole |
Search more.